bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • NewAmsterdam Pharma N.V. logo

    NewAmsterdam Pharma N.V.

    NAMS | NASDAQ
    Chart Builder DCF Calculator
    $23.05
    +$0.47 (+2.08%)
    Sep 22, 2026, 11:51 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $2.64B
    Enterprise Value
    $2.01B
    Beta
    0.09
    Average Volume
    1.22M
    Shares Outstanding (Diluted)
    123.37M
    Shares Change YoY
    9.65%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    NL00150012L7

    Price Performance

    Price Change 1M
    -19.0%
    Price Change 3M
    -28.1%
    Price Change 6M
    -27.2%
    Price Change YTD
    -35.9%
    Price Change 1Y
    -16.5%
    Price Change 3Y
    140.0%
    Price Change 5Y
    129.2%
    1M CAGR (ann.)
    -19.2%
    1Y CAGR (ann.)
    -15.5%
    5Y CAGR (ann.)
    17.9%
    All-Time CAGR
    14.4%

    Valuation

    PE Ratio
    -10.36
    Forward PE
    N/A
    PEG Ratio
    0.30
    Forward PEG
    0.59
    PS Ratio
    370.69
    Forward PS
    16.90
    PB Ratio
    4.18
    P/FCF Ratio
    -15.14
    P/Adj. FCF Ratio
    -11.69
    P/OCF Ratio
    -19.47
    EV/Sales
    281.69
    EV/EBIT
    -7.86
    EV/EBITDA
    -7.87
    EV/FCF
    -11.50
    Earnings Yield
    -9.7%
    FCF Yield
    -6.6%
    Adj. FCF Yield
    -8.6%

    Financial Health

    Net Cash
    $633.85M
    Total Debt
    $82K
    Cash & Short-Term Investments
    $633.85M
    Total Assets
    $704.45M
    Current Ratio
    9.03
    Quick Ratio
    9.03
    Debt / Equity Ratio
    0.00
    Debt / EBITDA
    -0.00
    Debt / FCF
    -0.00
    OCF / Debt
    -2,122.76
    Interest Coverage
    0.00
    Altman Z-Score
    19.76
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    92.2%
    Operating Profit Margin
    -3432.2%
    EBITDA Margin
    -3579.2%
    Net Profit Margin
    -3644.2%
    FCF Margin
    -2448.6%
    Adj. FCF Margin
    -3170.3%
    SBC / Revenue
    468.9%
    SBC Impact (per share)
    -29.5%

    Returns

    Return on Assets
    -36.8%
    Return on Equity
    -38.3%
    Return on Invested Capital
    -38.7%
    Return on Capital Employed
    -38.7%
    Return on Tangible Assets
    -36.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -30.7%
    Revenue CAGR 5Y
    -36.0%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    8.7%
    EPS CAGR 5Y
    33.5%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    1.0%
    FCF CAGR 5Y
    -43.3%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    10
    EPS Growth Next 3Y
    56.3%
    Revenue Growth Next 3Y
    378.0%
    Earnings Date
    Nov 3, 2026
    EPS Estimate (next Q)
    -$0.50
    EPS Growth Est (next Q)
    -18.0%
    Revenue Est (next Q)
    $7.54M
    Revenue Growth Est (next Q)
    2066.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $51.33
    Price Target Upside
    127.3%

    Cash Flow

    Operating Cash Flow
    $-174.07M
    Free Cash Flow
    $-174.36M
    Adj. Free Cash Flow
    $-225.76M
    FCF Per Share
    -$1.16
    OCF Per Share
    -$1.16
    OCF/S Ratio
    -2014.6%

    Income Statement

    Revenue
    $7.12M
    Gross Profit
    $6.56M
    Operating Income
    $-244.41M
    EBITDA
    $-254.88M
    Net Income
    $-259.5M
    EPS (Diluted)
    -$2.18
    Revenue / Employee
    $71.21K
    Profit / Employee
    $-2.6M
    Employees
    100

    © 2026 bestshares.com. All rights reserved.